BASF inorganic specialties divestiture creates new business named Callery

Current product portfolio includes a range of specialty alkoxide bases and borane derivatives.

BASF has created Callery as the new stand-alone entity born from BASF's divestment of its inorganic specialties business. The divestiture was facilitated by Edgewater Capital in combination with the Callery management team. Callery is a global leader in highly reactive chemistries, supplying products to the pharmaceutical, fine, and specialty chemical arenas.  

Callery's current product portfolio includes a range of specialty alkoxide bases and borane derivatives, as well as a variety of custom products based on the company's core competency in the handling of highly reactive compounds. Callery's world-class facility includes R&D labs, pilot plant, large-scale production facilities and all knowledge associated with existing and developmental products.

Bob Girton, member of Callery's Board of Directors, said: "We are grateful for all of the hard work by the transition team over the last several months for helping us carve out the Callery business from BASF with minimal impact on our customers. We are excited to join them in taking Callery to its next level of success and build on the business' commitment to environmental health and safety, a high level of product quality, and industry leading reagent and organometallic technology."

The company's products have enabled some of the world's most impressive innovations, including billion-dollar blockbuster drugs, agro chemicals, and other high performance products from electronics to polymer applications.

Soon, Callery will be announcing its new management team to lead the company on its growth path in the coming years. The company is committed to the continued delivery of innovative products that enable customer success.